CLLS

#5491
Cellectis S.A. American Depositary Shares
3.88
-3.72%
Sector:
Básica:
Profit Currency:
Rango diario
3.88
3.88
Rango anual
1.10
5.48
Cambio diario
-3.72%
Monthly Change
-5.13%
6 month change
+50.39%
Cambio anual
+198.46%
Cierres anteriores
4.03
Open
3.88
Bid
Ask
Low
3.88
High
3.88
Volumen
1
Open full chart

Financials

Overview Statement Statistics Dividends
Quarterly Annual
  • Market Capitalization N/A
  • Employee 222
  • Founded 1999
  • CEO André Choulika
  • Website www.cellectis.com
  • Headquarter France
  • FIGI BBG0084L1XN2
  • Industry Technology
Total revenue
Net income
Basic earnings per share (Basic EPS)
Total debt
Free cash flow
Cash & equivalents
Price to earnings ratio
—
Price to sales ratio
—
Dividends per share
—
Dividend yield %
—

Cellectis S.A. - American Depositary Shares

Cellectis is a French biopharmaceutical company. It develops genome-edited chimeric antigen receptor T-cell technologies for cancer immunotherapy. It has offices in Paris, New York City, and Raleigh, North Carolina.

Noticias